The role of matrix metalloproteinases (MMP) and their inhibitor in influenza a virus induced host lung injury

THE ROLE OF MATRIX METALLOPROTEINASES (MMP) AND THEIR INHIBITOR IN INFLUENZA A VIRUS-INDUCED HOST LUNG INJURY NG HUEY HIAN (B.Sc.(Hons.), NUS) A THESIS SUBMITTED FOR THE DEGREE OF MASTER OF SCIENCE DEPARTMENT OF MICROBIOLOGY NATIONAL UNIVERSITY OF SINGAPORE 2011 PUBLICATIONS Narasaraju T, Sim MK, Ng HH, Phoon MC, Shanker N, Lal SK and Chow VT (2009) ―Adaptation of human influenza H3N2 virus in a mouse pneumonitis model: insights into viral virulence, tissue tropism and host pathogenesis.‖ Microbes and Infection 11(1): 2-11 Narasaraju T, Ng HH, Phoon MC and Chow VT (2010) ―MCP-1 antibody treatment enhances damage and impedes repair of the alveolar epithelium in influenza pneumonitis.‖ American Journal of Respiratory Cell and Molecular Biology 42(6): 732-743 Narasaraju T, Yang E, Perumalsamy R, Ng HH, Poh WP, Liew AA, Phoon MC, Rooijen NV, Chow VT (2011) ―Excessive neutrophils and neutrophil extracellular traps contribute to acute lung injury of Influenza pneumonitis.‖ The American Journal of Pathology 179(1): 199-210 POSTERS PRESENTED AT INTERNATIONAL CONFERENCES Adaptation of Human Influenza H3N2 Virus in a Mouse Pneumonitis Model: Insights into Viral Virulence, Tissue Tropism and Host Pathogenesis Presented at the X International Symposium on Respiratory Viral Infections by The Macrae Group, Sentosa, Singapore, 28th Feb – 2nd March 2008 The Role of Matrix Metalloproteases in the Pathogenesis of Influenza Pneumonitis Presented at the 2010 Annual Scientific Meeting and Exhibition of the Australian Society of Microbiology, Sydney, Australia, 4th – 8th July 2010 i ACKNOWLEDGEMENTS I would like to express my heartfelt gratitude to: A/Prof Vincent Chow, who has been a most encouraging supervisor and for having faith in me and allowing me the opportunity to undertake this project His encouragement and supervision has allowed me to develop valuable critical thinking and skills of scientific reasoning which has benefited me greatly A/Prof Sim Meng Kwoon, for co-supervising me on this project, and for his invaluable guidance, constant support and understanding throughout the whole project, providing a platform for me to learn Dr Teluguakula Narasaraju, for being such an inspiring and important mentor for this project He thought me almost all the techniques I learnt for my honors and masters year and I am very grateful to be able to turn to him for guidance and advice whenever I am unsure Dr Seet Ju Ee, for taking time off her busy schedule to the scoring for the histopathology slides and for agreeing to my requests which could be quite confusing and tough at times Mrs Phoon, for being a motherly figure throughout my years in Microbiology and for her administrative and technical assistance Kelly, for being such a great help as the Laboratory Officer, constantly procuring reagents and helping in the day-to-day administrative matters for me Yong Chiat, Wu Yan, Audrey-Ann, Meilan, Jung Pu, Edwin, Youjin, Kai Sen, Wai Chii, Wee Peng, Fiona, Fabian, Hui Ann, Cynthia, Ivan - My past and present labmates, for their unfailing help and support We are like a big family and all the laughter and fun we shared will stay with me throughout my life Thank you all for being there when I needed advice or just needed a friend to talk to It has been quite a ride and I‘m glad we were all in this journey together Dad, Mum, Sis, Bro and my family – Thanks for understanding my crankiness and absence from several family events because of lab It is comforting to know that after a long day‘s work, I have a blissful home I can return to everyday Thank you for all the support ii TABLE OF CONTENTS Content Pages Publications i Posters presented at international conferences i Acknowledgements ii Table of Contents iii-vii Summary viii-ix List of tables x List of figures xi-xiii List of abbreviations xiv-xv Chapter 1: Introduction Chapter 2: Literature review 1-4 5-45 2.1 Background of Influenza virus 2.2 Influenza Pathogenesis 2.3 Occurrence and geographical distribution 6-7 2.4 Clinical Pathology of Influenza Virus 7-8 2.5 Influenza virus and host defences 2.6 Neutrophils 11-16 2.7 Neutrophils and Influenza virus-induced lung injury 17-20 2.8 Neutrophilic enzymes 20-24 2.9 Matrix Metalloproteinases 25-34 2.10 Gelatinases 34-39 2.11 Existing therapies for Influenza 39-43 2.12 Doxycycline 44-45 8-10 iii Chapter 3: Materials and Methods 46-68 3.1 Use of BALB/c Mice and Animal Husbandry 3.2 Intranasal infection of mice 46-47 3.3 Doxycycline treatment 47-48 3.4 Broncho-Alveolar Lavage Fluid (BALF) Collection from mice 3.5 BALF cell counts 3.5.1 Total BALF cell count using trypan blue exclusion 48-49 3.5.2 Differential BALF cell count using giemsa staining 49 3.6 Lowry Protein estimation assay of BALF and lung homogenate 50 3.7 Gelatinase Zymography 50-51 3.8 Western Blot Analysis 51-52 3.9 Extraction and preparation of lungs for histopathology 52-53 3.10 Immunohistochemistry 54-55 3.11 Homogenization of Lungs 53-54 3.12 Myeloperoxidase (MPO) Enzyme Activity Assay 54-55 3.13 Streaking of blood agar plate with lung homogenate 55-56 3.14 Total RNA Purification from animal tissues and mammalian cells 3.15 46 48 56 Quantitation and determination of purity and integrity of total RNA 56-57 3.16 Reverse Transcription 57-58 3.17 Classical PCR for viral gene detection 3.18 SYBR Green Real time analysis of genes 3.19 Cell Culture 3.20 Virus infection of LA-4 cells 58 58-60 61 iv 3.20.1 Seeding of cells in 24-well place or 6-well plate 3.20.2 Virus infection of LA-4 cells 3.20.3 Harvesting of cells and supernatant for subsequent experiments 3.21 Plaque assay for virus titre 3.21.1 Seeding of cells in 24-well plate 3.21.2 Infection of MDCK cells with virus 3.21.3 Preparation and addition of Avicel Overlay 64 3.21.4 Fixation and staining to visualise plaques 64 3.22 Statistical analysis 65 3.23 Summary of methodology 3.23.1 Summary of methodology (In Vitro) 66 3.23.2 Summary of methodology (In Vivo) 67-68 3.23.2a Mice Infection Experiment 67 3.23.2b Doxycycline Treatment Experiment 68 Chapter 4: Modulation of gelatinases by Influenza A virus 61-62 62 62-63 63 63-64 69-105 4.1 Results 4.1.1 Microarray analysis of MMP gene expression 69 4.1.2 Average weight of mice 70 4.1.3 Virus titres of mice lung homogenates determined by plaque assay 72 Immunohistochemical detection for influenza virus antigen in lung tissues 72 4.1.4 4.1.5 Histopathology of lung tissues of mice 4.1.6 Myeloperoxidase (MPO) assay in mice lung homogenates 69-93 75-76 79 v 4.1.7 Real-Time PCR analysis of gelatinases gene expression in lung Tissues 79 4.1.8 Western Blot analysis of gelatinases protein levels in BALF 82 4.1.9 Gelatinase zymography analysis of gelatinases protein activity in BALF 82 4.1.10 Cytopathic effect (CPE) of LA-4 cells 85 4.1.11 Classical PCR to detect virus presence in LA-4 cells 85 4.1.12 Virus titres of supernatant from LA-4 cells determined by plaque assay 86 Real-Time PCR analysis of gelatinases gene expression in LA-4 cells 89 4.1.14 Western Blot analysis of gelatinases protein levels in LA-4 cells 91 4.1.15 Gelatinase zymography of gelatinases protein activity in LA-4 cells 91 4.1.13 4.2 Discussion 4.2.1 Expression of MMPs in influenza pneumonitis 94-95 4.2.2 Mouse-adapted Influenza A/Aichi/2/68 P10 (H3N2) virus infection in mice 95-96 Mouse-adapted Influenza A/Aichi/2/68 P10 (H3N2) virus causes productive replication in LA4 cells 97 Evaluation of acute lung injury in mice infected with the mouse-adapted Influenza A/Aichi/2/68 P10 (H3N2) virus 97-98 Increase in MMPs expression and activity and their role in influenza virus-induced host lung injury 99-104 4.2.3 4.2.4 4.2.5 4.3 Conclusion 94-104 104-105 vi Chapter 5: Effects of doxycycline on influenza-induced inflammation and host lung injury 106-137 5.1 Results 5.1.1 Average weight of mice 106 5.1.2 Western Blot analysis of gelatinases protein levels in BALF 108 5.1.3 Gelatinase zymography analysis of gelatinases protein activity in BALF 108 5.1.4 Total inflammatory cell count in BALF 111 5.1.5 Differential inflammatory cell count in BALF 5.1.6 Myeloperoxidase (MPO) assay in mice lung homogenates 112 5.1.7 Virus titres of mice lung homogenates determined by plaque assay 115 5.1.8 BALF protein concentrations 115 5.1.9 Histopathology of lung tissues of mice 5.1.10 Western Blot of T1-α and Thrombomodulin protein levels in BALF 122 5.1.11 Blood agar streaking of mice lung homogenates 124 5.2 Discussion 5.2.1 Influenza as a Public Health Concern 5.2.2 Use of doxycycline (MMP inhibitor) in alleviating pulmonary conditions 127-128 5.2.3 Doxycycline treatment of mice infected with mouse-adapted Influenza A/Aichi/2/68 P10 (H3N2) virus 128-134 Conclusion 135-137 5.3 106-125 111-112 117-118 126-134 126 Chapter 6: Reference 138-157 Chapter 7: Appendices 158-161 vii SUMMARY Influenza pneumonitis has always been a considerable concern as it is associated with substantial morbidity and mortality and could lead to post-infection sequelae such as acute lung injury (ALI) or in more severe cases, acute respiratory distress syndrome (ARDS) Matrix metalloproteinases (MMPs), especially the gelatinases, contribute to the initial stage of ALI or ARDS pathogenesis due to their eminent ability to degrade major components of the basement membrane such as gelatin and collagen IV, thus resulting in damage of the epithelium and endothelium and consequentially, alveolarcapillary barrier disruption In this present study, we observed an increase in gelatinases MMP-2 and MMP-9 upon mouse-adapted influenza A/Aichi/2/68 (H3N2) P10 virus infection in a murine pneumonitis in vivo model and the acute inflammatory response elicited by virus infection results in massive infiltration of macrophages and neutrophils, which are sources of gelatinases In addition, in vitro infection of murine LA-4 alveolar epithelial cells demonstrates another source of gelatinases during influenza virus infection The host reponse to increase expression of gelatinases was accompanied by augmented epithelial and endothelial damage, as determined by respective elevated T1-α and thrombomodulin protein markers in the BALF and protein leakage into the airspaces We show here that oral administration of a low dose of doxycycline, a MMP inhibitor which inhibits gelatinases MMP-2 and MMP9, not only reduces inflammation following influenza virus infection in mice, but also leads to significant assauge of host lung injury by minimising the destruction of pulmonary endothelium and epithelium, thus lessening leakage of proteinaceous viii material into the airways Influenza-induced host lung injury is effectively improved by lower doses of doxycycline but when a higher dose of the drug is administered, inflammation was reduced to such a substantial level that renders the viral clearance inefficient, resulting in high virus load which has direct cytopathic effects on the host cells and eventually, further pulmonary damage It is thus vital to use a suitable dosage of doxycycline to reduce inflammation and gelatinase activities in influenza virus infection but not excessively, to alleviate host acute lung injury There is currently no effective strategy for preventing influenza-induced host lung injury apart from the use of prophylactic influenza vaccines and anti-viral drugs The data outlined in our study implicates excess MMP activity in the pathogenesis of influenza and doxycycline administration represents a promising therapeutic strategy by targeting MMPs and inflammation, for reducing immunopathology and might be an important approach for the treatment of influenza associated pulmonary injury ix 135 Pilcher BK, Wang M, Qin XJ, Parks WC, Senior RM and Welgus HG (1999) ―Role of matrix metalloproteinases and their inhibition in cutaneous wound healing and allergic contact hypersensitivity.‖ Annals of New York Academy of Sciences 878: 12-24 136 Plakokefalos ET, Markoulatos P, Spyrou N, Bei TA and Vamvakopoulos NC (2001) ―Molecular and phylogenetic analysis of haemagglutinin and neuraminidase sequences from recent human influenza type A (H3N2) viral isolates in Southern Greece.‖ Archives of Virology 146: 1899-1918 137 Plaza de los RM and Cruz-Coke R (1957) ―Influenzal pneumonia treated with cortisone and antibiotics.‖ Lancet 2: 845 138 Qiao J, Zhang M, Bi J, Wang X, Deng G, He G, Luan Z, Lv N, Xu T and Zhao L (2009) "Pulmonary fibrosis induced by H5N1 viral infection in mice." Respiratory Research 10(1): 107 139 Quinn MT and Gauss KA (2004) ―Structure and regulation of the neutrophil respiratory burst oxidase: comparison with nonphagocyte oxidases.‖ Journal of Leukocyte Biology 76: 760-781 140 Quispe-Laime AM, Bracco JD, Barberio PA, Campagne CG, Rolfo VE, Umberger R and Meduri GU (2010) ―H1N1 influenza A virus-associated acute lung injury: response to combination oseltamivir and prolonged corticosteroid treatment.‖ Intensive Care Medicine 36: 33–41 141 Ras GJ, Theron AJ, Andersen R, Taylor GW, Wilson R, Cole PJ and Van der MCA (1992) ―Enhanced release of elastase and oxidative inactivation of a-iprotease inhibitor by stimulated neutrophils exposed to Pseudornonas aeruginosa pigment1-hydroxyphenazine.‖ Journal of infectious Diseases 166: 568-573 142 Ratcliffe DR, Nolin SL and Cramer EB (1988) ―Neutrophil interaction with influenza-infected epithelial cells.‖ Blood 72(1): 142-149 143 Ray CG, Icenogle TB, Minnich LL, Copeland JG and Grogan TM (1989) ―The use of intravenous ribavirin to treat influenza virus-associated acute myocarditis.‖ Journal of Infectious Disease 159: 829-836 144 Reading PC, Pickett DL, Tate MD, Whitney PG, Job ER and Brooks AG (2009) ―Loss of a single N-linked glycan from the hemagglutinin of influenza virus is associated with resistance to collectins and increased virulence in mice.‖ Respiratory Research 10:117 151 145 Reading PC, Whitney PG, Pickett DL, Tate MD and Brooks AG (2010) ―Influenza viruses differ in ability to infect macrophages and to induce a local inflammatory response following intraperitoneal injection of mice.‖ Immunology and Cell Biology 88: 641–650 146 Rello J, Rodriguez A, Ibanez P, Socias L and Cebrian J (2009) ―Intensive care adult patients with severe respiratory failure caused by Influenza A (H1N1) virus in Spain.‖ Critical Care 13: R148 147 Ricou B, Nicod L, Lacraz S, Welgus HG, Suter PM and Dayer JM (1996) ―Matrix metalloproteinases and TIMP in acute respiratory distress syndrome.‖ American Journal of Respiratory and Critical Care Medicine 154: 346-352 148 Rotem CE (1957) ―Influenzal pneumonia treated with cortisone and antibiotics.‖ Lancet 2: 948 149 Rubenfeld GD, Caldwell E, Peabody E, Weaver J, Martin DP, Neff M, Stern EJ and Hudson LD (2005) ―Incidence and outcomes of acute lung injury.‖ New England Journal of Medicine 353: 1685–1693 150 Rundhaug EJ (2003) ―Matrix Metalloproteinases, Angiogenesis, and Cancer.‖ Clinical Cancer Research 9: 551–554 151 Ryan LK, Diamond G and Fredeking TM (2009) ―Modulation of influenzainduced morbidity and mortality in mice by doxycycline.‖ American Journal of Respiratory and Critical Care Medicine 179: A3257 152 Saladino R, Barontini M, Crucianelli M, Nencioni L, Sgarbanti R and Palamara AT (2010) ―Current Advances in Anti-Influenza Therapy.‖ Current Medicinal Chemistry 17(20): 2101-2140 153 Sagar J (2010) ―Doxycycline in clinical medicine.‖ Clinical Medicine Insights: Therapeutics.‖ 2: 133-136 154 Sakai S, Kawamata H, Mantani N, Kogure T, Shimada Y, Terasawa K, Sakai T, Imanishi N and Ochia H (2000) ―Therapeutic Effect of Anti-Macrophage Inflammatory Protein Antibody on Influenza Virus-Induced Pneumonia in Mice.‖ Journal of Virology 74(5): 2472–2476 155 Schmolke M and García-Sastre (2010) ―Evasion of innate and adaptive immune responses by Influenza A virus.‖ Cellular Microbiology 12(7): 873–880 156 Scholtissek C, Becht H and Drzeniek R (1967) ―Biochemical studies on the cytopathic effect of influenza viruses.‖ Journal of general Virology 1: 219-225 152 157 Segal AW (2005) ―How neutrophils kill microbes.‖ Annual Reviews of Immunology 23:197–223 158 Segura-Valdez L, Pardo A, Gaxiola M, Uhal BD, Becerril C and Selman M (2000) ―Upregulation of Gelatinases A and B, Collagenases and 2, and Increased Parenchymal Cell Death in COPD.‖ Chest 117: 684-694 159 Shapiro SD (2002) ―Neutrophil Elastase: Path Clearer, Pathogen Killer, or just Pathologic?‖ American Journal Respiratory Cell and Molecular Biology 26: 266–268 160 Shapiro SD, Goldstein NM, Houghton AM, Kobayashi DK, Kelley D and Belaaouaj A (2003) ―Neutrophil elastase contributes to cigarette smoke-induced emphysema in mice.‖ American Journal of Pathology 163: 2329–2335 161 Shinya K, Watanabe S, Ito T, Kasai N and Kawaoka Y (2007) ―Adaptation of an H7N7 equine influenza A virus in mice.‖ Journal of General Virology 88: 547553 162 Sibille Y (1990) ―Macrophages and polymorphonuclear neutrophils in lung defense and injury.‖ American Reviews of Respiratory Diseases 141(2): 471501 163 Sim DLC and Chow VTK (1999) ―The novel human HUEL (C4orf1) gene maps to chromosome 4p12-p13 and encodes a nuclear protein containing the nuclear receptor interaction motif.‖ Genomics 59: 224-233 164 Sim DLC, Yeo WM & Chow VTK (2002) ―The novel human HUEL (C4orf1) protein shares homology with the DNA-binding domain of the XPA DNA repair protein and displays nuclear translocation in a cell cycle-dependent manner.‖ The International Journal of Biochemistry and Cell Biology 34: 487-504 165 Smith JA (1994) ―Neutrophils, host defense, and inflammation: a double-edged Sword.‖ Journal of Leukocyte Biology 56: 672-686 166 Smith VA and Cook SD (2004) ―Doxycycline – a role in ocular surface repair.‖ British Journal of Ophthalmology 88: 619–625 167 Snoek-van B and Von den HWJ (2005) ―Zymographic techniques for the analysis of matrix metalloproteinases and their inhibitors.‖ BioTechniques 38: 73-83 153 168 Solomon A, Rosenblatt M, Li D, Liu Z, Monroy D, Ji Z, Lokeshwar LB and Pflugfelder CS (2000) ―Doxycycline inhibition of interleukin-1 in the corneal epithelium.‖ Investigative Ophthalmology and Visual Science 41: 2544-2557 169 Stamenkovic I (2003) ―Extracellular matrix remodelling: the role of matrix Metalloproteinases.‖ Journal of Pathology 200: 448–464 170 Sternlicht MD and Werb Z (2001) ―How Matrixmetalloproteinases regulate cell behavior.‖ Annual Review of Cell and Developmental Biology 17: 463–516 171 Subbarao K and Joseph T (2007) ―Scientific barriers to developing vaccines against avian influenza viruses.‖ Nature Reviews: Immunology 7: 267-278 172 Sumikoshi M, Hashimoto K, Kawasaki Y, Sakuma H, Suzutani T, Suzuki H and Hosoya M (2008) ―Human influenza virus infection and apoptosis induction in human vascular endothelial cells.‖ Journal of Medical Virology 80: 1072-1078 173 Sweet C and Smith H (1980) ―Pathogenesis of influenza virus.‖ Microbiology Reviews 44: 303–330 174 Szretter KJ, Gangappa S, Belser JA, Zeng H, Chen H, Matsuoka Y, Sambhara S, Swayne DE, Tumpey TM and Katz JM (2009) ―Early control of H5N1 Influenza virus replication by the type I interferon response in mice.‖ Journal of Virology 83(11): 5825-5834 175 Takanaka K and O‘Brien PJ (1975) ―Mechanisms of H2O2 formation by leukocytes: Properties of the NADPH Oxidase Activity of intact leukocytes.‖ Archives of Biochemistry and Biophysics 169: 436-442 176 Takiyama A, Wang L, Tanino M, Kimura T, Kawagishi N, Kunieda Y, Katano H, Nakajima H, Hasegawa H, Takagi T, Nishihara H, Sata T and Tanaka S (2010) "Sudden death of a patient with pandemic influenza (A/H1N1pdm) virus infection by acute respiratory distress syndrome." Japan Journal of Infectious Diseases 63(1): 72-74 177 Tate MD, Brooks AG and Reading PC (2008) ―The role of neutrophils in the upper and lower respiratory tract during influenza virus infection of mice.‖ Respiratory Research 9: 57-69 178 Taubenberger JK and Morens DM (2008) "The Pathology of Influenza Virus Infections." Annual Reviews of Pathology 3: 499–522 179 Taylor MJ, Makunde WH, McGarry HF, Turner JD, Mand S and Hoerauf A (2005) ―Macrofilaricidal activity after doxycycline treatment of Wuchereria 154 bancrofti: a double-blind, randomized placebo-controlled trial.‖ Lancet 365(9477): 2116-2121 180 Teti A (1992) ―Regulation of Cellular Functions by Extracellular Matrix.‖ Journal of the American Society of Nephrology 2: S83-S87 181 Torii K, Lida KI, Miyazaki Y, Saga S, Kondoh Y, Taniguchi H, Taki F, Takagi K, Matsuyama M and Suzuki R (1997) ―Higher concentrations of matrix metalloproteinases in bronchoalveolar lavage fluid of patients with adult respiratory distress syndrome.‖ American Journal of Respiratory and Critical Care Medicine 155: 43-46 182 Tran TH, Nguyen TL, Nguyen TD, Luong TS, Pham PM, Nguyen VC, Pham TS, Dong VC, Le TQM and Ngo TT (2004) ―Avian influenza A (H5N1) in 10 patients in Vietnam.‖ New England Journal of Medicine 350: 1179–1188 183 Vaccaro AC and Brody SJ (1981) ―Structural Features of Alveolar Wall Basement Membrane in the Adult Rat Lung.‖ The Journal of Cell Biology 91: 427-437 184 Viboud C, Grais RF, Lafont BAP, Miller MA and Simonsen L (2005) ―Multinational Impact of the 1968 Hong Kong Influenza Pandemic: Evidence for a smoldering pandemic.‖ Journal of Infectious Diseases 192: 233-248 185 Viboud C, Miller M, Olson D, Osterholm M and Simonsen L (2010) "Preliminary Estimates of Mortality and Years of Life Lost Associated with the 2009 A/H1N1 Pandemic in the US and Comparison with Past Influenza Seasons." PLoS Curr Influenza 20: (RRN1153) 186 Visse R and Nagase H (2003) ―Matrix Metalloproteinases and Tissue Inhibitors of Metalloproteinases: Structure, Function, and Biochemistry.‖ Circulatory Research 92: 827-839 187 Wahn H, Rüenauver N and Hammerschmidt S (2002) ―Effect of arachidonic and eicosapentaenoic acids on acute lung injury induced by hypochlorous acid.‖ Thorax 57: 1060–1066 188 Wang S, Le TQ, Chida J, Cisse Y, Yano M and Kido H (2010) ―Mechanisms of matrix metalloproteinase-9 upregulation and tissue destruction in various organs in influenza A virus infection.‖ The Journal of Medical Investigation 57: 26-34 189 Ware LB and Matthay MA (2000) ―The acute respiratory distress syndrome.‖ New England Journal of Medicine 342: 1334–1349 155 190 Warner RL, Bhagavathula N, Nerusu KC, Lateef H, Younkin E, Johnson KJ and Varani J (2004) ―Matrix metalloproteinases (MMPs) in acute lung inflammation : Induction of MMP-3 and MMP-9 in fibroblasts and epithelial cells following exposure to proinflammatory mediators in vitro.‖ Experimental and Molecular Pathology 76: 189-195 191 Weiss SJ, Peppin G, Ortiz X, Ragsdale C and Test ST (1985) ―Oxidative autoactivation of latent collagenase by human neutrophils.‖ Science 227: 747– 749 192 Weitzman SA and Gordon LI (1990) ―Inflammation and cancer: role of phagocyte-generated oxidants in carcinogenesis.‖ Blood 76: 655-663 193 Wells MA, Albrecht P, Daniel S and Ennis FA (1978) ―Host Defense Mechanisms Against Influenza Virus: Interaction of Influenza Virus with Murine Macrophages In Vitro.‖ Infection and Immunity 22(3): 758-762 194 World Health Organization, Cumulative Number of Confirmed Human Cases of Avian Influenza A (H5N1) Reported to WHO, 31 August 2010 (http://www.who.int/csr/disease/avian_influenza/country/cases_table_2010_08_3 1/en/index.html) 195 World Health Organization, Cumulative Number of Confirmed Human Cases of Avian Influenza A (H5N1) Reported to WHO, 15 August 2010 (http://gamapserver.who.int/h1n1/cases-deaths/h1n1_casesdeaths.html) 196 Witko-Sarsat V, Rieu P, Descamps-Latscha B, Lesavre P and HalbwachsMecarelli L (2000) ―Neutrophils: Molecules, Functions and Pathophysiological Aspects.‖ Laboratory Investigation 80(5): 617-653 197 Xu T, Qiao J, Zhao L, Wang G, He G, Li K, Tian Y, Gao M, Wang J, Wang H and Dong C (2006) ―Acute Respiratory Distress Syndrome Induced by Avian Influenza A (H5N1) Virus in Mice.‖ American Journal of Respiratory and Critical Care Medicine 174: 1011–1017 198 Yamada H, Le QT, Kousaka A, Higashi Y, Tsukane M and Kido H (2006) ―Sendai virus infection up-regulates trypsin I and matrix metalloproteinase-9, triggering viral multiplication and matrix degradation in rat lungs and lung L2 cells.‖ Archives of Virology 151: 2529–2537 199 Yao PM, Buhler J, d‘Ortho MP, Lebargy F, Delclaux C, Harf A and Lafuma C (1996) ―Expression of matrix metalloproteinase gelatinases A and B by cultured epithelial cells from human bronchial explants.‖ The Journal of Biological Chemistry 271(26): 15580-15589 156 200 Yao PM, Maitre B, Delacourt C, Buhler JM, Harf A and Lafuma C (1997) ―Divergent regulation of 92-kDa gelatinase and TIMP-1 by HBECs in response to IL-1β and TNF-α.‖ American Journal of Physiology 273: L866-L874 201 Yeo SJ, Kim SJ, Kim JH, Lee HJ and Kook YH (1999) ―Influenza A virus infection modulates the expression of type IV collagenase in epithelial cells.‖ Archives of Virology 144: 1361–1370 202 Yeo SJ, Yun YJ, Lyu MA, Woo SY, Woo ER, Kim SJ, Lee HJ, Park HK and Kook YH (2002) ―Respiratory syncytial virus infection induces matrix metalloproteinase-9 expression in epithelial cells.‖ Archives of Virology 147: 229–242 203 Yokoyama T, Tsushima K, Ushiki A, Kobayashi N, Urushihata K, Koizumi T and Kubo K (2010) ―Acute Lung Injury with Alveolar Hemorrhage Due to a Novel Swine-Origin Influenza A (H1N1) Virus.‖ Internal Medicine 49: 427-430 204 Yong VW, Power C, Forsyth P and Edwards DR (2001) ―Metalloproteinases in biology and pathology of the nervous system.‖ Nature Reviews Neuroscience 2: 502-511 205 Yoo HG, Shin BA, Park JS, Lee KH, Chay KO, Yang SY, Ahn BW and Jung YD (2002) ―IL-1β induces MMP-9 via reactive oxygen species and NFĸB in murine macrophage RAW 264.7 cells.‖ Biochemical and Biophysical Research Communications 298: 251-256 206 Yuki F, Akira S, Taro K and Hitoshi O (2009) ―Evolution of the M gene of the influenza A virus in different host species: large-scale sequence analysis.‖ Virology Journal 6: 67- 79 207 Zambon MC (1999) ―Epidemiology and pathogenesis of influenza.‖ Journal of Antimicrobial Chemotherapy 44: 3-9 208 Zemans RL, Colgan SP and Downey GP (2009) ―Transepithelial Migration of Neutrophils: Mechanisms and Implications for Acute Lung Injury.‖ American Journal of Respiratory and Cellular Molecular Biology 40: 519–535 157 CHAPTER 7: APPENDICES Sample Con R1 Con R1 Con R2 Con R2 INF B1 INF B1 INF B2 INF B2 INF B3 INF B3 INF B4 INF B4 INF B5 INF B5 β-actin 19.21 19.44 17.95 17.87 16.55 16.45 18.84 18.99 19.77 19.61 15.74 15.72 23.48 23.43 MMP 24.13 24.44 23.47 23.65 22.31 22.21 24.97 25.03 24.93 25.25 21.94 21.67 29.16 29.2 Sample Relative MMP2-β-actin Average reference expression 4.92 5.305 5.52 5.78 5.76 5.809 0.504 0.705149 5.76 6.13 6.04 5.16 5.64 6.2 5.95 5.68 5.77 Fold Change -1.41814 Table 7.1 Ct values obtained from Real-time PCR of MMP-2 gene for control uninfected and influenza virus-infected BALB/c mice on day post-infection timepoint (in vivo experiment) Data above was analyzed by real-time PCR Gene expression of MMP-2 was normalized to gene expression levels of housekeeping gene β-actin Graph summarizing the fold change of gene expression levels of the MMP-2 gene is shown in figure 4.8 (A) 158 Sample Con R3 Con R3 Con R4 Con R4 Con R5 Con R5 INF RB1 INF RB1 INF RB2 INF RB2 INF RB3 INF RB3 INF RB4 INF RB4 INF RB5 INF RB5 β-actin 16.82 16.72 19.73 19.8 17.99 18.12 22.73 22.66 14.76 14.77 18.19 18.16 27.78 27.8 27.46 27.14 MMP 22.03 22.42 25.65 25.55 23.23 23.23 27.76 28.03 20.9 20.94 23.94 24.14 35.36 34.31 36 34.43 MMP2-β-actin 5.21 5.7 5.92 5.75 5.24 5.11 5.03 5.37 6.14 6.17 5.75 5.98 7.58 6.51 8.54 7.29 Average 5.488333 6.436 Sample Relative reference expression Fold Change 0.947667 -1.92875 0.51847 Table 7.2 Ct values obtained from Real-time PCR of MMP-2 gene for control uninfected and influenza virus-infected BALB/c mice on day post-infection timepoint (in vivo experiment) Data above was analyzed by real-time PCR Gene expression of MMP-2 was normalized to gene expression levels of housekeeping gene β-actin Graph summarizing the fold change of gene expression levels of the MMP-2 gene is shown in figure 4.8 (A) 159 Sample Con R1 Con R1 Con R2 Con R2 INF B1 INF B1 INF B2 INF B2 INF B3 INF B3 INF B4 INF B4 INF B5 INF B5 β-actin 19.21 19.44 17.95 17.87 16.55 16.45 18.84 18.99 19.77 19.61 15.74 15.72 23.48 23.43 MMP 25.13 25.02 24.92 24.89 23.61 23.64 25.74 25.68 25.49 25.54 23.62 23.67 25.72 25.87 MMP9-β-actin 5.92 5.58 6.97 7.02 7.06 7.19 6.9 6.69 5.72 5.93 7.88 7.95 2.24 2.44 Average 6.3725 Sample reference Relative expression Fold Change -0.3725 1.294594249 1.295 Table 7.3 Ct values obtained from Real-time PCR of MMP-9 gene for control uninfected and influenza virus-infected BALB/c mice on day post-infection timepoint (in vivo experiment) Data above was analyzed by real-time PCR Gene expression of MMP-9 was normalized to gene expression levels of housekeeping gene β-actin Graph summarizing the fold change of gene expression levels of the MMP-9 gene is shown in figure 4.8 (B) 160 Sample Con R3 Con R3 Con R4 Con R4 Con R5 Con R5 INF RB1 INF RB1 INF RB3 INF RB3 INF RB4 INF RB4 INF RB5 INF RB5 β-actin 16.82 16.72 19.73 19.8 17.99 18.12 22.73 22.66 18.19 18.16 27.78 27.8 27.46 27.14 MMP 24.03 24.02 25.97 26.1 25.25 25.28 28.01 28 24.87 25 28.47 28.71 26.94 27.19 MMP-β-actin 7.21 7.3 6.24 6.3 7.26 7.16 5.28 5.34 6.68 6.84 0.69 0.91 -0.52 0.05 Average 6.911667 3.15875 Sample reference Relative expression Fold Change -3.75292 13.48157 13.48157 Table 7.4 Ct values obtained from Real-time PCR of MMP-9 gene for control uninfected and influenza virus-infected BALB/c mice on day post-infection timepoint (in vivo experiment) Data above was analyzed by real-time PCR Gene expression of MMP-9 was normalized to gene expression levels of housekeeping gene β-actin Graph summarizing the fold change of gene expression levels of the MMP-9 gene is shown in figure 4.8 (B) 161 Con 0h Con 0h Con 12h Con 12h Con 24h Con 24h Con 48h Con 48h Inf 0h Inf 0h Inf 12h Inf 12h Inf 24h Inf 24h Inf 48h Inf 48h MMP Mean 178.97 236.07 163.06 233.16 173.82 231.84 178.59 226.58 156.84 229.91 186.35 239.89 186.05 240.25 186.51 239.4 MMP Pixels 2444 4058 2665 4782 2625 3988 2289 4869 2300 4407 3414 5710 3435 5694 3804 6801 Absolute Intensity 437402.68 957972.06 434554.9 1114971.12 456277.5 924577.92 408792.51 1103218.02 360732 1013213.37 636198.9 1369771.9 639081.75 1367983.5 709484.04 1628159.4 Average Intensity % Relative to Control 697687.37 100 774763.01 100 690427.71 100 756005.265 100 686972.685 98.46425699 1002985.4 129.4570581 1003532.625 145.3494132 1168821.72 154.6049709 Table 7.5 Absolute intensities of bands obtained from densitometric analyses of MMP-2 Western blot bands for control uninfected and influenza virus-infected LA-4 cells (in vitro experiment) Graph depicting percentage of MMP-2 band desitometries in infected cells expressed relative to control cells at 0h, 12h, 24h and 48h timepoints are shown in figure 4.15 162 Ctrl 0h Ctrl 0h Ctrl 12h Ctrl 12h Ctrl 24h Ctrl 24h Ctrl 48h Ctrl 48h Inf 0h Inf 0h Inf 12h Inf 12h Inf 24h Inf 24h Inf 48h Inf 48h MMP Mean 11.98 11.85 12.98 11.85 99.2 116.15 199.3 188.76 11.98 11.85 12.98 12.45 54.38 130.75 159.98 152.81 MMP Pixels 101 99 99 69 522 551 313 427 101 99 89 69 647 496 856 975 Absolute Intensity 1209.98 1173.15 1285.02 817.65 51782.4 63998.65 62380.9 80600.52 1209.98 1173.15 1155.22 859.05 35183.86 64852 136942.88 148989.75 Average Intensity % Relative to Control 1191.565 100 1051.335 100 57890.525 100 71490.71 100 1191.565 100 1007.135 95.7958215 50017.93 86.40089203 142966.315 199.9788714 Table 7.6 Absolute intensities of bands obtained from densitometric analyses of MMP-9 Western blot bands for control uninfected and influenza virus-infected LA-4 cells (in vitro experiment) Graph depicting percentage of MMP-9 band desitometries in infected cells expressed relative to control cells at 0h, 12h, 24h and 48h timepoints are shown in figure 4.15 163 Ctrl 0h Ctrl 0h Ctrl 12h Ctrl 12h Ctrl 24h Ctrl 24h Ctrl 48h Ctrl 48h Inf 0h Inf 0h Inf 12h Inf 12h Inf 24h Inf 24h Inf 48h Inf 48h MMP Mean 7.31 7.71 23.58 19.82 11.78 21.82 7.93 20.12 7.31 7.71 15.51 19.65 13.83 19.81 11.51 24.29 MMP Pixels 265 1010 595 2461 284 2123 176 1342 265 1010 501 2549 993 3099 230 2042 Absolute Intensity 1937.15 7787.1 14030.1 48777.02 3345.52 46323.86 1395.68 27001.04 1937.15 7787.1 7770.51 50087.85 13733.19 61391.19 2647.3 49600.18 Average Intensity % Relative to Control 4862.125 100 31403.56 100 24834.69 100 14198.36 100 4862.125 100 28929.18 92.12070224 37562.19 151.2488781 26123.74 183.9912497 Table 7.7 Absolute intensities of bands obtained from densitometric analyses of MMP-2 gelatinase zymography bands for control uninfected and influenza virus-infected LA-4 cells (in vitro experiment) Graph depicting percentage of MMP-2 band desitometries in infected cells expressed relative to control cells at 0h, 12h, 24h and 48h timepoints are shown in figure 4.16 164 Ctrl 0h Ctrl 0h Ctrl 12h Ctrl 12h Ctrl 24h Ctrl 24h Ctrl 48h Ctrl 48h Inf 0h Inf 0h Inf 12h Inf 12h Inf 24h Inf 24h Inf 48h Inf 48h MMP Mean 14.76 8.81 124.42 25.54 81.41 9.02 42.06 10.38 39.08 7.57 173.11 24.2 125.15 19.96 127.95 17.43 MMP Pixels 963 305 1142 680 1037 505 911 285 703 307 1543 760 1194 852 1361 468 Absolute Intensity 14213.88 2687.05 142087.64 17367.2 84422.17 4555.1 38316.66 2958.3 27473.24 2323.99 267108.73 18392 149429.1 17005.92 174139.95 8157.24 Average Intensity % Relative to Control 8450.465 100 79727.42 100 44488.635 100 20637.48 100 14898.615 176.3052684 142750.365 179.0480176 83217.51 187.0534126 91148.595 441.6653341 Table 7.8 Absolute intensities of bands obtained from densitometric analyses of MMP-9 gelatinase zymography bands for control uninfected and influenza virus-infected LA-4 cells (in vitro experiment) Graph depicting percentage of MMP-9 band desitometries in infected cells expressed relative to control cells at 0h, 12h, 24h and 48h timepoints are shown in figure 4.16 165 ... disruption of the capillary-alveolar barrier function results in the leakage of inflammatory exudates, edema fluid and plasma proteins into the lung interstitium and alveolar spaces and the collapse of. .. et al, 2010) 2.5 Influenza virus and host defences During an acute influenza virus infection, both arms of immunity: Innate and adaptive, are important in protecting the host against the pathogen... pathogen The former has a primary goal of limiting virus growth and activating the onset of the adaptive arm, in which viral clearance takes place (Tate et al, 2008) In the early innate phase of host